{
  "paper_metadata": {
    "pmid": "38974244",
    "title": "BRCA-associated hereditary male cancers: can gender affect the prevalence and spectrum of germline pathogenic variants?",
    "extraction_summary": "Extracted genetic variant information specifically for BRCA2, including penetrance data for affected and unaffected carriers."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.4284dup",
      "protein_notation": "p.Gln1429fs",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "male, age unspecified",
        "phenotype": "MBC and melanoma"
      },
      "penetrance_data": {
        "total_carriers_observed": 26,
        "affected_count": 17,
        "unaffected_count": 9,
        "uncertain_count": null,
        "penetrance_percentage": 65.4,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "MBC and melanoma",
          "evidence_sentence": "The BRCA2 variant named c.4284dup (p.Gln1429fs) has been observed in both melanoma and MBC."
        }
      ],
      "functional_data": {
        "summary": "Frameshift variant leading to truncated protein.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "Low frequency rates (0.82% in women with breast and/or ovarian cancer).",
      "evidence_level": "Moderate evidence based on family history and clinical presentation.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Variant detected in multiple patients with different cancer types.",
      "key_quotes": [
        "The BRCA2 variant named c.4284dup (p.Gln1429fs) has been observed in both melanoma and MBC."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.7681C>T",
      "protein_notation": "p.Gln2561Ter",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 2,
        "demographics": "male, age unspecified",
        "phenotype": "MBC and PC"
      },
      "penetrance_data": {
        "total_carriers_observed": 26,
        "affected_count": 17,
        "unaffected_count": 9,
        "uncertain_count": null,
        "penetrance_percentage": 65.4,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "MBC",
          "evidence_sentence": "Another BRCA2 variant named c.7681C>T (p.Gln2561Ter) was present in one individual with MBC and one with PC."
        },
        {
          "individual_id": "Case_3",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "PC",
          "evidence_sentence": "Another BRCA2 variant named c.7681C>T (p.Gln2561Ter) was present in one individual with MBC and one with PC."
        }
      ],
      "functional_data": {
        "summary": "Nonsense variant leading to truncated protein.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "Low frequency rates (1.03% in women with breast and/or ovarian cancer).",
      "evidence_level": "Moderate evidence based on family history and clinical presentation.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Variant detected in multiple patients with different cancer types.",
      "key_quotes": [
        "Another BRCA2 variant named c.7681C>T (p.Gln2561Ter) was present in one individual with MBC and one with PC."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.6078_6079del",
      "protein_notation": "p.Glu2028fs",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 2,
        "demographics": "male, age unspecified",
        "phenotype": "MBC"
      },
      "penetrance_data": {
        "total_carriers_observed": 26,
        "affected_count": 17,
        "unaffected_count": 9,
        "uncertain_count": null,
        "penetrance_percentage": 65.4,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_4",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "MBC",
          "evidence_sentence": "The BRCA2 variants named c.6078_6079del (p.Glu2028fs) have been detected each in two different MBC patients."
        },
        {
          "individual_id": "Case_5",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "MBC",
          "evidence_sentence": "The BRCA2 variants named c.6078_6079del (p.Glu2028fs) have been detected each in two different MBC patients."
        }
      ],
      "functional_data": {
        "summary": "Frameshift variant leading to truncated protein.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "Not specified.",
      "evidence_level": "Moderate evidence based on family history and clinical presentation.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Variant detected in multiple patients with MBC.",
      "key_quotes": [
        "The BRCA2 variants named c.6078_6079del (p.Glu2028fs) have been detected each in two different MBC patients."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 5",
      "table_caption": "Germline BRCA PVs/LPVs harbored by patients with MBC, PCa, PC or melanoma.",
      "variants_extracted": 3
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 3,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant BRCA2 variants and penetrance data were extracted."
  }
}